1. Home
  2. EH vs LQDA Comparison

EH vs LQDA Comparison

Compare EH & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EH
  • LQDA
  • Stock Information
  • Founded
  • EH 2014
  • LQDA 2004
  • Country
  • EH China
  • LQDA United States
  • Employees
  • EH N/A
  • LQDA N/A
  • Industry
  • EH Military/Government/Technical
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EH Industrials
  • LQDA Health Care
  • Exchange
  • EH Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • EH 1.2B
  • LQDA 1.3B
  • IPO Year
  • EH 2019
  • LQDA 2018
  • Fundamental
  • Price
  • EH $16.21
  • LQDA $13.17
  • Analyst Decision
  • EH Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • EH 3
  • LQDA 9
  • Target Price
  • EH $24.80
  • LQDA $27.67
  • AVG Volume (30 Days)
  • EH 1.5M
  • LQDA 3.0M
  • Earning Date
  • EH 05-26-2025
  • LQDA 08-06-2025
  • Dividend Yield
  • EH N/A
  • LQDA N/A
  • EPS Growth
  • EH N/A
  • LQDA N/A
  • EPS
  • EH N/A
  • LQDA N/A
  • Revenue
  • EH $57,950,389.00
  • LQDA $14,144,000.00
  • Revenue This Year
  • EH $102.87
  • LQDA $185.38
  • Revenue Next Year
  • EH $60.58
  • LQDA $350.95
  • P/E Ratio
  • EH N/A
  • LQDA N/A
  • Revenue Growth
  • EH 167.93
  • LQDA N/A
  • 52 Week Low
  • EH $10.40
  • LQDA $8.26
  • 52 Week High
  • EH $29.76
  • LQDA $19.41
  • Technical
  • Relative Strength Index (RSI)
  • EH 43.14
  • LQDA 36.80
  • Support Level
  • EH $15.98
  • LQDA $13.60
  • Resistance Level
  • EH $17.07
  • LQDA $14.63
  • Average True Range (ATR)
  • EH 0.64
  • LQDA 0.96
  • MACD
  • EH 0.03
  • LQDA -0.40
  • Stochastic Oscillator
  • EH 25.44
  • LQDA 0.46

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: